Cymbalta ads driving share in crowded market

Share this article:
Lilly said its "Depression Hurts" ad campaign for Cymbalta is working, helping drive the drug's gains in share of the crowded market. “Patients have told us, ‘finally, someone understands what I'm going through,'” Cymbalta marketing director Phyllis Ferrell told the Indianapolis Star.

Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...